Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

1.070 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.070
Bid (Size) 1.030 (5)
Ask (Size) 1.170 (4)
Prev. Close 1.070
Today's Range 1.070 - 1.070
52wk Range 1.010 - 2.940
Shares Outstanding 118,947,830
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AcelRx to Host First Quarter 2021 Financial Results Call and Webcast on May 17, 2021
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release first quarter financial results after market close on Monday, May 17, 2021. AcelRx... 
From PR Newswire
AcelRx Announces an Investigator-Initiated Study of DSUVIA® for Use in Same-Day Total Joint Replacement
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised... 
From PR Newswire

Performance

YTD
-14.40%
-14.40%
1 Month
-20.15%
-20.15%
3 Month
-59.47%
-59.47%
6 Month
-26.21%
-26.21%
1 Year
-30.07%
-30.07%

More News

Read More
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure
From PR Newswire
AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors
From PR Newswire
AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings
From PR Newswire
AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
From PR Newswire
Thinking about buying stock in Atossa Therapeutics, AMC Entertainment, T2 Biosystems, AcelRx Pharmaceuticals, or ENDRA Life Sciences?
From PR Newswire
First Week of December 17th Options Trading For AcelRx Pharmaceuticals (ACRX)
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags KURA DMAC SNCA
From Benzinga
AcelRx To Test Dsuvia In Patients On Buprenorphine Requiring A Surgical Procedure
Tags Biotech General Opioids
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.